BDC-2034

N/A

Report date: 2024/02/05 14:01:54

Base Information

Drug NameBDC-2034

Drug Alias NameBDC-2034

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-CEAToll like receptor 8 agonistsToll like receptor 7 agonists

TargetsCarcinoembryonic antigenToll like receptor 8Toll like receptor 7

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBolt Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesBolt Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A